StockDuty ← Dashboard Oct 28, 2026 09:05 PM ET
SignalGeopolitics

FDA scientists opposed Trump administration’s move to ease peptide access

FDA scientists' opposition signals regulatory conflict over Trump's peptide access policy.

What happened: FDA scientific staff largely opposed a plan to ease access to unproven injectable peptides favored by HHS secretary Robert F Kennedy Jr, and had limited input in drafting the policy posted online Wednesday. Why it matters: The policy covers peptides promoted in the wellness industry for building muscle, healing injuries and boosting energy, and drew fierce pushback from agency scientists.
FDA scientific staff largely opposed a plan to ease access to unproven injectable peptides favored by HHS secretary Robert F Kennedy Jr, and had limited input in drafting the policy posted online Wednesday.
The policy covers peptides promoted in the wellness industry for building muscle, healing injuries and boosting energy, and drew fierce pushback from agency scientists.
Sources